Validated HPLC-MS/MS method for determination of quetiapine in human plasma

被引:70
作者
Barrett, B.
Holcapek, M.
Huclova, J.
Borek-Dohalsky, V.
Fejt, P.
Memec, B.
Jelinek, I.
机构
[1] CEPHA Sro, Dept Bioanalyt Lab, Plzen 32300, Czech Republic
[2] Univ Pardubice, Dept Analyt Chem, Fac Chem Technol, Pardubice 53210, Czech Republic
[3] Charles Univ Prague, Dept Analyt Chem, Prague 12843 2, Czech Republic
关键词
quetiapine HPLC; MS/MS; plasma; pharmacokinetic study;
D O I
10.1016/j.jpba.2007.03.034
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A validated, highly sensitive and selective high-pressure liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed for the quantitative determination of quetiapine (QUE) in human Na(2)EDTA plasma with mass spectrometry (MS) detection. Clozapine (CLO) was employed as an internal standard. Samples were extracted using solid phase extraction (SPE). Oasis HLB cartridges and the concentration of quetiapine was determined by isocratic HPLC-MS/MS. The SRM mode was used for MS/MS detection. The method was validated over a concentration range of 1.0-382.2 ng/mL. Inter- and intra-day precision and accuracy of the proposed method were characterized by relative standard deviation (R.S.D.) and the percentage of deviation, respectively; both were lower than 8%. The developed method was employed in the pharmacokinetic study of quetiapine.(c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:498 / 505
页数:8
相关论文
共 14 条
[1]   Quetiapine (Seroquel®) concentrations in seven postmortem cases [J].
Anderson, DT ;
Fritz, KL .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2000, 24 (04) :300-304
[2]  
Davis PC, 1999, J PHARMACEUT BIOMED, V20, P271
[3]   Clinical pharmacokinetics of quetiapine - An atypical antipsychotic [J].
DeVane, CL ;
Nemeroff, CB .
CLINICAL PHARMACOKINETICS, 2001, 40 (07) :509-522
[4]  
DILETTI E, 1991, INT J CLIN PHARM TH, V29, P1
[5]   Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography:: a simple tool for therapeutic drug monitoring [J].
Frahnert, C ;
Rao, ML ;
Grasmäder, K .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 794 (01) :35-47
[6]   Fully automated on-line quantification of quetiapine in human serum by solid phase extraction and liquid chromatography [J].
Hasselstrom, J ;
Linnet, K .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 798 (01) :9-16
[7]   HPLC analysis of the novel antipsychotic drug quetiapine in human plasma [J].
Mandrioli, R ;
Fanali, S ;
Ferranti, A ;
Raggi, MA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 30 (04) :969-977
[8]   Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: An open-label trial in adolescents with psychotic disorders [J].
McConville, BJ ;
Arvanitis, LA ;
Thyrum, PT ;
Yeh, C ;
Wilkinson, LA ;
Chaney, RO ;
Foster, KD ;
Sorter, MT ;
Friedman, LM ;
Brown, KL ;
Heubi, JE .
JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (04) :252-260
[9]   Screening for basic drugs in 2-mL urine samples by dual-plate overpressured layer chromatography and comparison with gas chromatography-mass spectrometry [J].
Pelander, A ;
Ojanperä, I ;
Sistonen, J ;
Rasanen, I ;
Vuori, E .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2003, 27 (04) :226-232
[10]  
SEROQUEL, 2003, SUMMARY PRODUCT CHAR, V23